The current financial score of Catheter Precision Inc is 6.39. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 1.02M, representing a year-over-year increase of 380.66%, while its net profit experienced a year-over-year increase of 49.99%.
The current valuation score of Catheter Precision Inc is 9.56. Its current P/E ratio is -0.01, which is -2357.24% below the recent high of 0.33 and -1700.00% above the recent low of -0.26.
No earnings forecast score is currently available for Catheter Precision Inc. The Healthcare Equipment & Supplies industry's average is 7.77.
The current price momentum score of Catheter Precision Inc is 5.31. Currently, the stock price is trading between the resistance level at 0.20 and the support level at 0.12, making it suitable for range-bound swing trading.
The current institutional shareholding score of Catheter Precision Inc is 5.00. The latest institutional shareholding proportion is 11.31%, representing a quarter-over-quarter increase of 962.85%.
The current risk assessment score of Catheter Precision Inc is 1.32. The company's beta value is -1.02. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.